Rekvina Laboratories
REKVINALAB · Retail > Trading Listing date: July 26, 2013

Stock Price vs Company Growth
1d
0.0%
1w
5.9%
1m
13.1%
3m
7.9%
6m
700.0%
1y
700.0%
5y
55.4%
10y
24.0%
all
5.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 36 0%
31.7
46.6
Company Overview

Sales
1.27 Cr
Growth: 999.0%
Profit after Tax
-0.25 Cr
Growth: 7.2%
Micro Cap
21.7 Cr
P/S: 17.1x
Industry P/S: 1.4x
Fundamentals

Sales (Cr) ₹ 1.27
Growth 999.0%
EBITDA N/A
P/S 17.1x
Dividend 0.0%
P/E -144.0x
Book Value ₹ -0.65
PEG Ratio -0.1x
ROE 91.3%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

From a small domestic company at inception in middle of 80’s, Rekvina Laboratories has grown formidably to be an integrated, Indian pharmaceutical company. The company has introduced the concept of Dispersible Kid Tablets for Pediatric patients. The company’s unique formulations include its prestigious product ‘REKFA’, (Essential Fatty Acid - in Capsule, Cream & Pediatric Drop).
Investors (1)